FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 2.834
AS - Asia 1.565
NA - Nord America 718
SA - Sud America 315
AF - Africa 32
OC - Oceania 1
Totale 5.465
Nazione #
RU - Federazione Russa 2.465
US - Stati Uniti d'America 683
SG - Singapore 450
CN - Cina 442
BR - Brasile 249
HK - Hong Kong 214
VN - Vietnam 167
IT - Italia 150
KR - Corea 112
DE - Germania 84
IN - India 74
AR - Argentina 34
JP - Giappone 31
FI - Finlandia 23
NL - Olanda 19
MX - Messico 18
EC - Ecuador 16
FR - Francia 14
GB - Regno Unito 14
IQ - Iraq 14
AT - Austria 12
BD - Bangladesh 12
ZA - Sudafrica 11
IE - Irlanda 10
PL - Polonia 10
ID - Indonesia 9
UA - Ucraina 9
CA - Canada 7
ES - Italia 7
MA - Marocco 6
UZ - Uzbekistan 6
KE - Kenya 5
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
BH - Bahrain 3
EG - Egitto 3
IL - Israele 3
PH - Filippine 3
PK - Pakistan 3
TN - Tunisia 3
TR - Turchia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
PE - Perù 2
SE - Svezia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 5.465
Città #
Moscow 858
Santa Clara 216
Hong Kong 211
Singapore 180
Hefei 155
San Jose 118
Seoul 111
Ashburn 76
Ho Chi Minh City 66
Bengaluru 59
Hanoi 42
Munich 40
Beijing 33
Dallas 32
Naples 25
Los Angeles 23
The Dalles 23
São Paulo 20
Nuremberg 16
Milan 13
Rio de Janeiro 13
Amsterdam 12
Helsinki 11
Dublin 10
Falkenstein 9
Vitulazio 9
Brooklyn 8
Mexico City 8
Turku 8
Baghdad 7
Caserta 7
Chennai 7
Haiphong 7
New York 7
Warsaw 7
Belo Horizonte 6
Curitiba 6
Da Nang 6
Quito 6
Rome 6
Tashkent 6
Boardman 5
Brasília 5
Council Bluffs 5
Formosa 5
Hải Dương 5
Johannesburg 5
Nairobi 5
Ribeirão Preto 5
Vienna 5
Angri 4
Atlanta 4
Chicago 4
Florence 4
Guarulhos 4
Orem 4
Poços de Caldas 4
Tokyo 4
Trentola-Ducenta 4
Verona 4
Asunción 3
Bắc Ninh 3
Campinas 3
Campo Grande 3
Fortaleza 3
Frankfurt am Main 3
Gravataí 3
Lappeenranta 3
Manama 3
Quilmes 3
Riyadh 3
Santo André 3
Thái Bình 3
Tianjin 3
Torre del Greco 3
Alghero 2
Ambato 2
Arezzo 2
Baku 2
Bari 2
Bauru 2
Biên Hòa 2
Brescia 2
Buenos Aires 2
Bến Tre 2
Cachoeiro de Itapemirim 2
Cairo 2
Caldas Novas 2
Camden 2
Canoas 2
Caracas 2
Carapicuíba 2
Caruaru 2
Caxias do Sul 2
Dakar 2
Duhok 2
Eunápolis 2
Feira de Santana 2
Filottrano 2
Go Vap 2
Totale 2.663
Nome #
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 126
Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy 125
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 121
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 120
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 115
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis 111
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis 108
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 105
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 104
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 104
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 104
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 104
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 99
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 98
Anticoagulation in atrial fibrillation. A large real-world update 97
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 97
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 96
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 94
Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study 93
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 91
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy 90
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 90
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 89
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy 88
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 88
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 84
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): A pilot study 83
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 81
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 81
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 80
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 79
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 78
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 77
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease 77
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 75
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 74
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 74
PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population 73
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 73
β-blockers: Their new life from hypertension to cancer and migraine 73
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 72
Prognostic impact of right ventricular dysfunction in patients with severe aortic stenosis treated with trans-catheter aortic valve implantation 72
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 72
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus 72
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 71
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 70
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 68
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 68
Change in prevalence of ATTR variants in Italy: results from a national survey 68
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 67
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 67
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 66
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis 66
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 65
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? 65
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry 64
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 62
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 61
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 58
Post-procedural fever after Transcatheter Aortic Valve Implantation (TAVI). A multi-centric study 57
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age 57
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 56
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 55
Use of Smartphone-operated ECG for home ECG surveillance in COVID-19 patients 54
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 53
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 50
Response to correspondence on 'Change in prevalence of ATTR variants in Italy' 46
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug 41
Impatto prognostico delle sindromi geriatriche nella gestione dell’amiloidosi cardiaca da transtiretina 16
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study 15
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular Disease 14
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 11
Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients 11
Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics 10
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR: The GASS-TAVR Study 3
Totale 5.542
Categoria #
all - tutte 14.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 2 0 0 0 3 0 1 0
2023/2024137 0 0 4 1 2 0 1 29 9 15 33 43
2024/2025947 5 42 13 61 155 116 188 47 75 79 69 97
2025/20264.452 176 427 329 194 379 2.288 238 114 173 134 0 0
Totale 5.542